Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

AlphaBiomics

Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies.
2018
2-10
London, England, United Kingdom
BiotechnologynologyHealth CareLife SciencePrecision Medicine

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

114.07K

Last Funding Amount

114.07K

Last Funding Date

05-11-2018

Revenue

Less than $1M

People

Founders